Completed Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma NCT00413075 Conditions Adenoma, Adenosarcoma, Adnexal Diseases, +89 more Locations Yale New Haven Hospital — New Haven, Connecticut, United States Columbia University - Herbert Irving Cancer Center — New York, United States New York University Cancer Institute — New York, United States M.D. Anderson Cancer Center — Houston, Texas, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors NCT00413322 Conditions Adenoma, Adenosarcoma, Adnexal Diseases, +92 more Locations Mayo Clinic Arizona — Scottsdale, Arizona, United States University of Nebraska — Omaha, Nebraska, United States Portsmouth Regional Hospital Hematology/Oncology Clinic — Portsmouth, New Hampshire, United States View Trial Details
